Management of Hematologic Disorders

  • Author: David Aboulafia, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • ART initiation or alteration may be used to treat thrombocytopenia in patients not at risk for bleeding; other treatment options include vincristine and anabolic steroids[Ahn 1990; Mintzer 1985]
  • Eltrombopag or romiplostim may be appropriate for some patients at risk for bleeding who have had insufficient response to other therapeutic options

Action required

Keywords: Hematologic Complications

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.